Shintaro Yamazaki

Dr. Shintaro Yamazaki

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
KEKiyoko Ebisawa
Kiyoko Ebisawa
SYShintaro Yamazaki
Shintaro Yamazaki
YKYuki Kimura
Yuki Kimura
MKMitsuhiko Kashio
Mitsuhiko Kashio
KKKatsumi Kurito
Katsumi Kurito
TTTadatoshi Takayama
Tadatoshi Takayama
Appendicitis and incarcerated hernia are frequently encountered reasons of emergency surgery for acute abdomen. The treatment in early stages of each condition is generally simple, but when these conditions are combined, the symptoms become slightly complicated, obscuring specific symptoms. Especially the lack of symptoms for appendicitis leads to delayed diagnosis, resulting in high morbidity. Amyand hernia, which contains appendix in its inguinal hernia sac, is perhaps more familiar to the general surgeons than De Garengeot hernia, which is an incarcerated femoral hernia with an appendix in its sac. We report the case of a 90-year-old female with incarcerated femoral hernia who underwent emergency hernioplasty only to reveal an inflamed appendix in its sac. The patient underwent both appendectomy and hernia repair simultaneously with synthetic mesh and was discharged on postoperative day 7 without any complications. We will also discuss the physical and radiological findings of De Garengeot hernia.

10 November 2020 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YMYusuke Mitsuka
Yusuke Mitsuka
SYShintaro Yamazaki
Shintaro Yamazaki
NYNao Yoshida
Nao Yoshida
MYMasahiro Yan
Masahiro Yan
THTokio Higaki
Tokio Higaki
TTTadatoshi Takayama
Tadatoshi Takayama
Background: Surgical indications for liver metastases from pancreatic ductal adenocarcinoma (PDAC) are lacking because outcomes are usually poor. However, liver resection and the recent progress in perioperative chemotherapy have been observed to improve survival. Methods: We performed liver resection for liver metastases from PDAC only under the following criteria: (1) liver-only metastasis, (2) up to three tumors, and (3) no increase in the number of metastases during the 3-month observation period. No limitations were placed on the location or size of liver metastasis. In this study, we aimed to validate our surgical criteria and analyze factors affecting survival in patients with PDAC. Results: Seventy-nine patients underwent curative resection for PDAC between 2005 and 2015. Seventy-one patients experienced recurrence, with liver-only recurrence in 17 patients. Among these, nine patients underwent liver resection and eight did not. The median survival time was significantly better for patients who underwent liver resection (55 months) than for those with other recurrences (17.5 months, p = 0.016). The median survival after liver recurrence was significantly better in the liver resection group (31 months) than in the non-liver resection group (7 months, p = 0.0008). The median disease-free interval (DFI) after pancreatectomy was significantly longer in the liver resection group (21 months; range, 3–44 months) than in the non-liver resection group (3 months; range, 2–7 months; p = 0.02). Conclusion: Good indications for liver metastases from PDAC include solitary metachronous tumors and longer DFIs.

17 December 2015 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
TKTomoharu Kurokawa
Tomoharu Kurokawa
SYShintaro Yamazaki
Shintaro Yamazaki
YMYusuke Mitsuka
Yusuke Mitsuka
MMMasamichi Moriguchi
Masamichi Moriguchi
MSMasahiko Sugitani
Masahiko Sugitani
TTTadatoshi Takayama
Tadatoshi Takayama
In hepatocellular carcinoma (HCC), des-r-carboxy prothrombin (DCP) more accurately reflects the malignant potential than alpha-fetoprotein (AFP). Next-generation DCP (NX-DCP) was created to overcome some of the limitations of conventional DCP. This study assessed the predictive value of NX-DCP for vascular invasion in HCC. We prospectively studied 82 consecutive patients who were scheduled to undergo resection for HCC. Patients were divided into two groups according to the presence or absence of pathological vascular invasion. The predictive powers of AFP, conventional DCP, and NX-DCP for vascular invasion were compared by receiver operating characteristic curve analysis, and correlations with tumour markers and the presence of vascular invasion were assessed. Vascular invasion was pathologically confirmed in 21 patients (positive group) and absent in 61 patients (negative group). The NX-DCP level was significantly higher in the positive group than in the negative group (510.0 mAU ml−1 (10–98 450) vs 34.0 mAU ml−1 (12–541), P<0.0001), while the AFP level did not differ significantly between the groups (9.7 ng ml−1 (1.6–43 960.0) vs 11.0 ng ml−1 (1.6–1650.0), P=0.49). The area under the curve (AUC) of NX-DCP (AUC=0.813, sensitivity=71.4%, 1−specificity=13.1%) had good sensitivity for the prediction of vascular invasion, while the AUC of AFP was 0.550 (sensitivity=28.6%, 1−specificity=1.60%). The suitable cutoff value for identifying pathological vascular invasion in HCC was 33 mm (AUC: 0.783, sensitivity=71.43%, 1−specificity=11.48%). The NX-DCP level can be used to predict the presence of vascular invasion in HCC.

12 February 2014 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
HNHisashi Nakayama
Hisashi Nakayama
TTTadatoshi Takayama
Tadatoshi Takayama
TOTakao Okubo
Takao Okubo
THTokio Higaki
Tokio Higaki
YMYutaka Midorikawa
Yutaka Midorikawa
SYShintaro Yamazaki
Shintaro Yamazaki

23 April 2015 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SYShintaro Yamazaki
Shintaro Yamazaki
TTTadatoshi Takayama
Tadatoshi Takayama
THTokio Higaki
Tokio Higaki
MMMasamichi Moriguchi
Masamichi Moriguchi
NYNao Yoshida
Nao Yoshida
YTYoichi Teshima
Yoichi Teshima

24 August 2017 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SOShunji Okada
Shunji Okada
SYShintaro Yamazaki
Shintaro Yamazaki
TKTeruo Kaiga
Teruo Kaiga
TFTomoya Funada
Tomoya Funada
MKMitsugu Kochi
Mitsugu Kochi
TTTadatoshi Takayama
Tadatoshi Takayama
The nutritional status plays a pivotal role during anticancer therapy. This study analyzed whether nutritional status influences the outcomes in the era of FOLFOX/FIRI therapy. The patients were divided into two groups according to whether the nutritional status was well (serum albumin level ≥ 3.8 g/dL or a ≥ 1.0 g/dL increase as compared with the value before chemotherapy) or not before and 2 and 6 months after the start of chemotherapy. Chemotherapy-related adverse events (AE), treatment effect, and compliance were evaluated according to the nutritional status. The progression-free survival (PFS) and overall survival (OS) were assessed based on the nutritional status at 6 months. Between 2010 and 2013, data on 108 consecutive patients were analyzed. At 2 months after chemotherapy, the hematotoxicic AE and the value of tumor markers did not differ significantly. The non-hematotoxic AE were less frequent in patients in the well-nourished group (grade 2, 15.9 vs. 38.5%, p < 0.01). Based on the nutritional status at 6 months after chemotherapy, the hematotoxicic AE (grade 3, 9 vs. 19.5%, p = 0.03) and non-hematotoxic AE (grade 2, 31.3 vs. 51.2%, p = 0.04; grade 3, 6.0 vs. 24.4%, p < 0.01) were less frequent, and the median CEA value (5.3 vs. 27.75 mg/L, p < 0.01) was significantly lower in the well-nourished group. The median PFS (364 vs. 233 days, p < 0.01) and 5-year OS (26.5 vs. 11.1%, p = 0.01) are significantly better in the well-nourished group. The well-nourished at initial 6 months may predict a better treatment response and fewer adverse events in FOLFOX/FIRI chemotherapy.